Efficacy of Chemotherapy after EGFR-TKIs Resistance in 191 Patients with Unknow EGFR Gene Mutation in Advanced Lung Adenocarcinoma

Efficacy of Chemotherapy after EGFR-TKIs Resistance in 191 Patients with Unknow EGFR Gene Mutation in Advanced Lung Adenocarcinoma

Background and objective Subsequent chemotherapy were needed in patients with advanced pulmonary adenocarcinoma experiencing disease progression after epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) treatment. The study is to explore factors potentially influencing efficacy o...

Full description

Bibliographic Details
Main Authors: Ping HE, Yan WANG, Sheng YANG, Shufei YU, Ziping WANG, Junling LI, Bin WANG, Xuezhi HAO, Hongyu WANG, Xingsheng HU, Xiangru ZHANG, Yuankai SHI
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2013-10-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Epidermal growth factor receptor tyrosine kinase inhibitor
Pemetrexed
Platinum
Drug resistance
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2013.10.06

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2013.10.06

Similar Items